Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atara Biotherapeutics, Inc. - Common Stock
(NQ:
ATRA
)
7.420
+0.160 (+2.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atara Biotherapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 06, 2025
Via
Benzinga
Atara Biotherapeutics Provides Regulatory Updates on EBVALLO™ (tabelecleucel)
May 05, 2025
From
Atara Biotherapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 24, 2025
Via
Benzinga
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Operational Progress
March 07, 2025
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Insights into Atara Biotherapeutics's Upcoming Earnings
November 11, 2024
Via
Benzinga
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025
From
Atara Biotherapeutics, Inc.
Via
Business Wire
ATRA Investors Have Opportunity to Join Atara Biotherapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm
January 27, 2025
From
The Schall Law Firm
Via
Business Wire
FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs
January 21, 2025
FDA halts Atara's EBVALLO and ATA3219 trials over manufacturing issues. Atara eyes $60 million milestone from Pierre Fabre upon EBVALLO approval.
Via
Benzinga
Exposures
Product Safety
Atara Biotherapeutics Provides Update on Clinical Programs Related to EBVALLO™ (tabelecleucel) and ATA3219
January 21, 2025
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Nasdaq Down 150 Points; Morgan Stanley Earnings Top Estimates
January 16, 2025
Via
Benzinga
Atara Stock Plunges To 3-Month Low After FDA Blocks Blood Cancer Drug: Retail's Buying The Dip
January 16, 2025
CEO Cokey Nguyen expressed confidence in resolving the issue, expecting resubmission and potential approval within six months of addressing the manufacturing compliance concerns.
Via
Stocktwits
Exposures
Product Safety
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
January 16, 2025
Via
Benzinga
Exposures
Fossil Fuels
US Stocks Edge Lower; Retail Sales Increase Less Than Expected
January 16, 2025
Via
Benzinga
Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLOTM (tabelecleucel)
January 16, 2025
From
Atara Biotherapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 14, 2025
Via
Benzinga
Atara Biotherapeutics to Participate at the 7th Annual Evercore ISI HealthCONx Conference
November 27, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference
November 13, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress
November 12, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Sidoti Events, LLC's Virtual November Micro-Cap Conference
November 12, 2024
Via
ACCESSWIRE
Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
November 05, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 04, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 06, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Crude Oil Down 1%; Dollar Tree Shares Tumble After Downbeat Earnings
September 04, 2024
Via
Benzinga
Exposures
Fossil Fuels
Atara Biotherapeutics (ATRA) Stock Is Up 20%: What's Going On?
September 04, 2024
Atara Biotherapeutics shares are trading higher by 20% Wednesday morning. The company announced a $36 million registered direct offering.
Via
Benzinga
Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
September 04, 2024
Via
Benzinga
Atara Biotherapeutics Announces $36 Million Registered Direct Offering
September 03, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
ATRA Stock Earnings: Atara Biotherapeutics Misses EPS, Misses Revenue for Q2 2024
August 12, 2024
ATRA stock results show that Atara Biotherapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Atara Biotherapeutics Announces Second Quarter 2024 Financial Results, Operational Progress and Leadership Update
August 12, 2024
From
Atara Biotherapeutics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.